Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Poseida Therapeutics (PSTX)

Annual Return

Over the past 3 years, PSTX has had an average annual return of +135.37%, outperforming the benchmark SPY, which returned +24.21% annual.

Over the past 5 years, PSTX has had an average annual return of +3.56%, underperforming the benchmark SPY, which returned +11.41% annual.

Since Jul 10, 2020, PSTX has had an average annual return of -10.11%, underperforming the benchmark SPY, which returned +16.42% annual.

202520242023202220212020
-1.04%+185.70%-36.61%-22.16%-37.93%-28.53%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025-1.04%-1.04%
2024+2.38%+15.13%-19.46%-24.11%+23.53%-2.36%+20.93%-19.00%+0%-17.12%+292.81%+3.12%+185.70%
2023+31.31%-18.24%-45.86%-14.30%-14.01%-22.45%-1.74%+20.85%+13.80%-15.10%+32.14%+25.88%-36.61%
2022-30.25%-23.14%+22.75%-31.04%-26.53%+13.66%-3.51%+32.92%+6.68%+16.13%+11.23%+16.22%-22.16%
2021-20.69%+26.89%-13.50%-1.98%-9.72%+18.58%-19.07%+6.55%-15.63%-12.07%+8.43%-2.03%-37.93%
2020-15.44%-27.66%-5.53%+29.75%+0.88%-5.51%-28.53%

Drawdown analysis of Poseida Therapeutics (PSTX)

The maximum drawdown for the PSTX was -90.03%, occurring on Aug 3, 2023. This drawdown has not yet recovered.

The current PSTX drawdown is -41.54%.

Since Jul 10, 2020 PSTX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-90.03%Jul 20, 2020765Aug 3, 2023OngoingOngoingOngoing
-15.24%Jul 10, 20202Jul 14, 20202Jul 16, 20204